Pradeep Patni (Akumentis)

I am extremely happy to share that very recently Akumentis received ET Ascent award for – “The Emerging Pharma Company for the Year”. This is the third in a series of awards we got this year.

The success and the transition in Akumentis have been possible through Go to Market Strategy conducted by SMSRC in Dec 2020 and the guidelines laid out for future. Right execution with no deviation ensured right results, the fruits of which we are currently enjoying.

The restructuring helped the firm to declutter and focus on right product mix to right Drs as well as increased productivity and consequently profitability.

Brand prioritization into Power & Focus acted as growth drivers and collectively they contribute to 80% to total business with 52% growth over last year.

SMSRC came up with disruptive approach which had huge impact on Akumentis performance ensuring a 11 rank jump and increased Market share. In this financial year also Akumentis is equally productive and showing significant growth over LY.

We are sure that this is just the beginning and going forward Akumentis will invariably continue to climb further up in the ranks and have a gratifying performance. We also take your input on consistent delivery coming only with strong focus and smart hard work and your exhortations do help the team to further pull up the boots to make it happen.

Thank you Sanjoy !!

Pradeep Patni

Introduction

 

Please complete the form below to access and download the Resylica Technical Dossier. The dossier provides detailed information on the technology, mode of action, performance, applications, safety profile, and environmental characteristics.

Fields marked with an asterisk () are required.*
Your information will be handled confidentially and in accordance with our Privacy Policy.

Error: Contact form not found.